{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T21:01:12Z","timestamp":1780174872519,"version":"3.54.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bmcl.2026.130684","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:29:48Z","timestamp":1778758188000},"page":"130684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multifunctional quinoline-based hydrazones as promising antidiabetic agents: experimental and computational insights"],"prefix":"10.1016","volume":"138","author":[{"given":"Aditi","family":"Kalakwade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini S.","family":"Kavalapure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Gharge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Gudasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriram D.","family":"Ranade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar G.","family":"Alegaon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramith","family":"Ramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.R.","family":"Prashantha Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Manu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130684_bb0005","doi-asserted-by":"crossref","first-page":"31349","DOI":"10.1038\/s41598-025-16661-7","article-title":"Introduction of new quinolone-2-thio-acetamide-propane hydrazide-benzimidazole derivatives as new \u03b1-glucosidase and \u03b1-amylase inhibitors","volume":"15","author":"Nikfar","year":"2025","journal-title":"Sci Rep"},{"issue":"153","key":"10.1016\/j.bmcl.2026.130684_bb0010","article-title":"Expression of PPAR-\u03b3 TF by newly synthesized thiazolidine-2, 4-diones to manage glycemic control: insights from in silico, in vitro and experimental pharmacology in wistar rats","author":"Gharge","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2026.130684_bb0015","doi-asserted-by":"crossref","unstructured":"Noreen F, Ullah S, Mali SN, Khan A, Hussain J, Alshammari A, Albekairi NA, Jawarkar RD, Yadav S, Al-Harrasi A, Shafiq Z. Synthesis, in vitro, and in silico studies of 7-fluorochromone based thiosemicarbazones as \u03b1-glucosidase inhibitors. Sci Rep 2025, 21;15(1):9816. DOI:https:\/\/doi.org\/10.1038\/s41598-025-90156-3.","DOI":"10.1038\/s41598-025-90156-3"},{"issue":"139","key":"10.1016\/j.bmcl.2026.130684_bb0020","article-title":"Arylureidoaurones: synthesis, in vitro \u03b1-glucosidase, and \u03b1-amylase inhibition activity","volume":"1","author":"Kazempour-Dizaji","year":"2023","journal-title":"Bioorg Chem"},{"issue":"150","key":"10.1016\/j.bmcl.2026.130684_bb0025","article-title":"Design, synthesis and bioevaluation of new vanillin hybrid as multitarget inhibitor of \u03b1-glucosidase, \u03b1-amylase, PTP-1B and DPP4 for the treatment of type-II diabetes","volume":"1","author":"Huneif","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2026.130684_bb0030","doi-asserted-by":"crossref","unstructured":"Aroua LM, Alosaimi AH, Alminderej FM, Messaoudi S, Mohammed HA, Almahmoud SA, Chigurupati S, Albadri AE, Mekni NH. Synthesis, molecular docking, and bioactivity study of novel hybrid benzimidazole urea derivatives: a promising \u03b1-amylase and \u03b1-glucosidase inhibitor candidate with antioxidant activity. Pharmaceutics 2023, 30;15(2):457. DOI:https:\/\/doi.org\/10.3390\/pharmaceutics15020457.","DOI":"10.3390\/pharmaceutics15020457"},{"key":"10.1016\/j.bmcl.2026.130684_bb0035","doi-asserted-by":"crossref","unstructured":"Alvarado Salazar JA, Valdes M, Cruz A, Moreno de Jes\u00fas B, Pati\u00f1o Gonz\u00e1lez D, Olivares Corichi IM, Tamay Cach F, Mendieta Wejebe JE. In silico and in vivo evaluation of novel 2-Aminobenzothiazole derivative compounds as antidiabetic agents. Int J Mol Sci 2025, 22;26(3):909. DOI:https:\/\/doi.org\/10.3390\/ijms26030909.","DOI":"10.3390\/ijms26030909"},{"issue":"150","key":"10.1016\/j.bmcl.2026.130684_bb0040","article-title":"Design, synthesis and bioevaluation of new vanillin hybrid as multitarget inhibitor of \u03b1-glucosidase, \u03b1-amylase, PTP-1B and DPP4 for the treatment of type-II diabetes","volume":"1","author":"Huneif","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2026.130684_bb0045","doi-asserted-by":"crossref","unstructured":"Dalbanjan NP, Bheemayya L, Kadapure AJ, Eelager MP, Swamy TC, Kamble RR, SK PK. In vitro and in silico pharmacological profiling of 3-(4, 5-diaryl-1H-imidazol-2-yl) quinoline-2-amine hybrids. ASPET Discov 2025, 1;1:100004. DOI:https:\/\/doi.org\/10.1016\/j.aspetd.2025.100004.","DOI":"10.1016\/j.aspetd.2025.100004"},{"key":"10.1016\/j.bmcl.2026.130684_bb0050","doi-asserted-by":"crossref","unstructured":"Savegnago L, Vieira AI, Seus N, Goldani BS, Castro MR, Lenard\u00e3o EJ, Alves D. Synthesis and antioxidant properties of novel quinoline\u2013chalcogenium compounds. Tetrahedron Lett 2013, 2;54(1):40-4. DOI:https:\/\/doi.org\/10.1016\/j.tetlet.2012.10.067.","DOI":"10.1016\/j.tetlet.2012.10.067"},{"issue":"143","key":"10.1016\/j.bmcl.2026.130684_bb0055","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ejmech.2017.10.046","article-title":"Quinoline derivatives bearing pyrazole moiety: synthesis and biological evaluation as possible antibacterial and antifungal agents","volume":"1","author":"El Shehry","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130684_bb0060","doi-asserted-by":"crossref","unstructured":"Keri RS, Patil SA. Quinoline: a promising antitubercular target. Biomed Pharmacother 2014 1;68(8):1161-75. DOI:https:\/\/doi.org\/10.1016\/j.biopha.2014.10.007.","DOI":"10.1016\/j.biopha.2014.10.007"},{"key":"10.1016\/j.bmcl.2026.130684_bb0065","doi-asserted-by":"crossref","unstructured":"Xie ZF, Chai KY, Piao HR, Kwak KC, Quan ZS. Synthesis and anticonvulsant activity of 7-alkoxyl-4, 5-dihydro-[1, 2, 4] triazolo [4, 3-a] quinolines. Bioorg Med Chem Lett 2005, 1;15(21):4803-5. DOI:https:\/\/doi.org\/10.1016\/j.bmcl.2005.07.051.","DOI":"10.1016\/j.bmcl.2005.07.051"},{"key":"10.1016\/j.bmcl.2026.130684_bb0070","doi-asserted-by":"crossref","unstructured":"Chen YL, Chen IL, Lu CM, Tzeng CC, Tsao LT, Wang JP. Synthesis and anti-inflammatory evaluation of 4-anilinofuro [2, 3-b] quinoline and 4-phenoxyfuro [2, 3-b] quinoline derivatives. Part 3. Bioorg Med Chem. 2004, 15;12(2):387\u201392. DOI:https:\/\/doi.org\/10.1016\/j.bmc.2003.10.051.","DOI":"10.1016\/j.bmc.2003.10.051"},{"key":"10.1016\/j.bmcl.2026.130684_bb0075","doi-asserted-by":"crossref","unstructured":"Savegnago L, Vieira AI, Seus N, Goldani BS, Castro MR, Lenard\u00e3o EJ, Alves D. Synthesis and antioxidant properties of novel quinoline\u2013chalcogenium compounds. Tetrahedron Lett 2013, 2;54(1):40-4. DOI:https:\/\/doi.org\/10.1016\/j.tetlet.2012.10.067.","DOI":"10.1016\/j.tetlet.2012.10.067"},{"issue":"116","key":"10.1016\/j.bmcl.2026.130684_bb0080","article-title":"Design, synthesis, and molecular docking study of some 2-((7-chloroquinolin-4-yl) amino) benzohydrazide Schiff bases as potential Eg5 inhibitory agents","volume":"1","author":"Kavalapure","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2026.130684_bb0085","article-title":"Novel 2, 4-thiazolidinedione-Quinoline hybrid molecules as rev-erb\u03b1 modulators for the treatment of diabetes mellitus","volume":"22","author":"Vunnam","year":"2025","journal-title":"J Mol Struct"},{"issue":"10","key":"10.1016\/j.bmcl.2026.130684_bb0090","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1039\/C5MD00280J","article-title":"Novel quinoline derivatives as potent in vitro \u03b1-glucosidase inhibitors: in silico studies and SAR predictions","volume":"6","author":"Taha","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmcl.2026.130684_bb0095","doi-asserted-by":"crossref","unstructured":"Taha M, Sultan S, Imran S, Rahim F, Zaman K, Wadood A, Rehman AU, Uddin N, Khan KM. Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies. Bioorg Med Chem 2019, 15;27(18):4081-8. DOI:https:\/\/doi.org\/10.1016\/j.bmc.2019.07.035.","DOI":"10.1016\/j.bmc.2019.07.035"},{"key":"10.1016\/j.bmcl.2026.130684_bb0100","doi-asserted-by":"crossref","unstructured":"Alharbi O, Alsaedi WH, Alsehli M, Althagafi SH, Alharbi HY, Asiri YM, Ramu R, Al-Ghorbani M. Novel Quinoline-and Naphthalene-incorporated Hydrazineylidene\u2013Propenamide analogues as antidiabetic agents: Design, synthesis, and computational studies. Pharmaceuticals 2024, 15;17(12):1692. DOI:https:\/\/doi.org\/10.3390\/ph17121692.","DOI":"10.3390\/ph17121692"},{"key":"10.1016\/j.bmcl.2026.130684_bb0105","doi-asserted-by":"crossref","unstructured":"Pravin NJ, Kavalapure RS, Gharge S, Alegaon SG, Ranade SD, Wong LS, Ramu R, M RC. Synthesis and in vitro biological evaluation of quinolone-based Hydrazones as potential antidiabetic agents targeting key metabolic enzymes. ACS Omega 2025, 22;10(30):33712-30. DOI:https:\/\/doi.org\/10.1021\/acsomega.5c04663.","DOI":"10.1021\/acsomega.5c04663"},{"key":"10.1016\/j.bmcl.2026.130684_bb0110","article-title":"Synthesis and evaluation of quinoline\u2013quinazoline hybrids as potential EGFR inhibitors","author":"Kavalapure","year":"2026","journal-title":"Results Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130684_bb0115","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/D4MD00689E","article-title":"Novel rhodanine\u2013thiazole hybrids as potential antidiabetic agents: a structure-based drug design approach","volume":"16","author":"Gharge","year":"2025","journal-title":"RSC Med Chem"},{"issue":"280","key":"10.1016\/j.bmcl.2026.130684_bb0120","article-title":"Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione\u2019s in fructose induced insulin resistant rats","author":"Ranade","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"157","key":"10.1016\/j.bmcl.2026.130684_bb0125","article-title":"Design, synthesis and molecular dynamics simulations of thiazole-based hydrazones targeting MDA-MB-231 breast cancer cells","author":"Alegaon","year":"2025","journal-title":"Bioorg Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130684_bb0130","article-title":"Structure-based insights into fatty acid modulation of lipid-sensing nuclear receptors PPAR\u03b4\/\u03b3 for glycemic regulation","author":"Gharge","year":"2025","journal-title":"Aspects Mol Med"},{"issue":"125","key":"10.1016\/j.bmcl.2026.130684_bb0135","article-title":"Structure-guided development of Quinoline derivatives targeting kinesin spindle protein","author":"Kavalapure","year":"2025","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130684_bb0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/08927022.2025.2477276","article-title":"Novel quinoline\u2013imidazole derivatives as inhibitors of mycobacterium tuberculosis: an integrated approach combining molecular dynamics and in-vitro studies","volume":"51","author":"Khebude","year":"2025","journal-title":"Mol Simul"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130684_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1134\/S106816202501011X","article-title":"Thiazolidine based Quinazoline hybrids: synthesis, docking, DFT, molecular dynamic study, and in vitro antidiabetic evaluation","volume":"51","author":"Gharge","year":"2025","journal-title":"Russian J Bioorga Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T20:24:21Z","timestamp":1780172661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S0960894X26001514"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130684","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifunctional quinoline-based hydrazones as promising antidiabetic agents: experimental and computational insights","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130684"}}